Study of LY3039478 in Healthy Participants

Summary

The study involves one dose of LY3039478 given by mouth followed by an intravenous infusion (IV) (via a tube linked to a small needle in the vein) of LY3039478. The results of this study will help to answer the following research questions: * How much LY3039478 gets into the blood stream when given by mouth as a capsule compared to when given by an IV * How long it takes the body to remove the study drug * The safety of LY3039478 and any side effects that might be associated with it Participation in the study is expected to last up to 7 weeks. There will be screening, a single study period, and a follow-up.

Timeline

Start

2016-10-04

Primary completion

2016-11-11

Completion

2016-11-11

Drugs

Indications

No indication recorded.